Transfer Pricing Litigation

OCT 18, 2012

MDW explained the Supreme Court dismissal in GlaxoSmithKline Inc. v. The Queen, sending it back to the Tax Court to include “embedded intangibles” in the price of the active ingredient.


Request More information:


    Share: